Enzo Biochem Inc (ENZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 04-2025 | 01-2025 | 10-2024 | 07-2024 | 04-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,701 | -4,911 | -3,376 | -26,078 | -12,697 |
| Depreciation Amortization | 955 | 637 | 319 | 1,272 | 874 |
| Accounts receivable | -377 | -554 | -17 | 2,477 | 2,475 |
| Accounts payable and accrued liabilities | -61 | -942 | -324 | -7,737 | -7,654 |
| Other Working Capital | -7,886 | -7,700 | -6,378 | -8,254 | -16,693 |
| Other Operating Activity | 834 | 2,454 | 786 | 12,061 | 8,521 |
| Operating Cash Flow | $-14,236 | $-11,016 | $-8,990 | $-26,259 | $-25,174 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -904 | -518 | -448 | -545 | -422 |
| Other Investing Activity | 5,000 | 5,000 | 5,000 | 0 | 0 |
| Investing Cash Flow | $4,096 | $4,482 | $4,552 | $-545 | $-422 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -79 | -37 | -37 | -110 | -110 |
| Dividend Paid | -5,324 | -5,324 | N/A | N/A | N/A |
| Other Financing Activity | -163 | -163 | -163 | -4,083 | -474 |
| Financing Cash Flow | $-5,566 | $-5,524 | $-200 | $-4,193 | $-584 |
| Exchange Rate Effect | 28 | -16 | 2 | -5 | -37 |
| Beginning Cash Position | 52,371 | 52,371 | 52,371 | 83,373 | 83,373 |
| End Cash Position | 36,693 | 40,297 | 47,735 | 52,371 | 57,156 |
| Net Cash Flow | $-15,678 | $-12,074 | $-4,636 | $-31,002 | $-26,217 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,236 | -11,016 | -8,990 | -26,259 | -25,174 |
| Capital Expenditure | -904 | -518 | -448 | -545 | -422 |
| Free Cash Flow | -15,140 | -11,534 | -9,438 | -26,804 | -25,596 |